Print Friendly, PDF & Email


Vetigenics begins canine bladder cancer trial

May 23, 2024
Animal Health | Headline Analysis US start-up Vetigenics has commenced its pilot clinical trial for a canine anti-cPD1 monoclonal antibody....
Read More

First canine patient receives Vetigenics’ fully canine anti-CTLA4 monoclonal antibody for oral melanoma

November 7, 2023
Two fully funded pilot studies to treat cancer free for pet owners who bring their dogs to research sites. PHILADELPHIA,...
Read More

Vetigenics’ Canibody platform attracting more potential collaborators

June 30, 2023
US pet therapeutics start-up Vetigenics is seeing increased interest from potential collaborators in its Canibody. Adriann Sax, the co-founder and...
Read More

Enhancing Canine Wellness: The Promise of Immunotherapy for Dogs

June 9, 2023
Given that dogs are widely regarded as ‘man’s best friend’, it makes sense that we are constantly striving to find...
Read More

Vetigenics Announces Second Discovery Collaboration with a Major Animal Health Pharma

November 8, 2022
New partnership established to explore multiple novel therapeutic antibodies for treating challenging pet diseases. Read More
Read More

Vetigenics Announces Publication of Comprehensive Preclinical Data for Anti-Canine CTLA4 Monoclonal Antibody

January 5, 2022
Published study confirms validity of the first entirely canine phage display technology to generate unique canine immunotherapy for treating canine...
Read More

Vetigenics Receives Startup of the Year Award from Penn Center for Innovation

December 3, 2021
Successful creation of the first entirely canine phage display platform for research and development of antibody immunotherapy spurs recognition for...
Read More

Vetigenics Announces Discovery Collaboration With Merck Animal Health

November 2, 2021
Partnership extended to explore multiple novel therapeutic antibodies for treating challenging pet diseases PHILADELPHIA, Nov. 2, 2021 /PRNewswire/ -- VETIGENICS,...
Read More

Animal Health Innovation USA | Virtual Event

June 16, 2021
Please join us on June 16 at 12:45pm to learn more about Vetigenics as a Innovation Showcase Finalist at the...
Read More

Vetigenics Aims to Solve Challenges in Canine Immunotherapy Discovery and Development

July 21, 2020
Adriann Sax has been appointed to advance Vetigenics from an academic start-up to an independent animal health biotech company. Ms...
Read More

Share this page

.elementor-icon, a.skip-link{display:none!important;} .print-img img{margin:0 auto!important} .elementor-element-23751c5 img.attachment-full {max-width:100%!important} .dogs.print-no{display:none!important;} .print-text-align-center{text-align:center!important;} { display: none!important; }